Processes for the production of solid dressings for treating wounded tissue
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-013/00
A61K-009/70
A61L-015/16
A61L-015/00
출원번호
US-0882872
(2007-08-06)
등록번호
US-8445009
(2013-05-21)
발명자
/ 주소
MacPhee, Martin
Beall, Dawson
출원인 / 주소
STB, Ltd
대리인 / 주소
Cozen O'Connor
인용정보
피인용 횟수 :
1인용 특허 :
76
초록▼
Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dres
Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen and liquid compositions useful for preparing the haemostatic layer(s) of these dressings or for treating wounded tissue in a mammal.
대표청구항▼
1. A process for producing a solid dressing for treating wounded tissue in a mammal comprising: (a) forming a liquid aqueous mixture of a fibrinogen component selected from the group consisting of human fibrinogen and bovine fibrinogen, and a fibrinogen activator selected from the group consisting o
1. A process for producing a solid dressing for treating wounded tissue in a mammal comprising: (a) forming a liquid aqueous mixture of a fibrinogen component selected from the group consisting of human fibrinogen and bovine fibrinogen, and a fibrinogen activator selected from the group consisting of human thrombin, bovine thrombin and recombinant human thrombin, at a temperature of 2° C. to 8° C., where said liquid aqueous mixture contains up to 9% γ-γ dimers; (b) reducing the temperature of said aqueous mixture to form a frozen aqueous mixture, wherein said frozen aqueous mixture contains up to 9% γ-γ dimers; and (c) reducing the moisture content of said frozen aqueous mixture to produce a solid dressing having a haemostatic layer consisting essentially of said fibrinogen component and said fibrinogen activator, wherein said haemostatic layer contains up to 9% γ-γ dimers. 2. The process of claim 1, further comprising at least one support layer. 3. The process of claim 2, wherein said support layer comprises a backing material. 4. The process of claim 2, wherein said support layer comprises an internal support material. 5. The process of claim 2, wherein said support layer comprises a resorbable material. 6. The process of claim 3, wherein said solid dressing further comprising at least one physiologically acceptable adhesive between said haemostatic layer and said backing layer. 7. The process of claim 5, wherein said resorbable materials is selected from the group consisting of proteinaceous materials and carbohydrate substances. 8. The process of claim 7, wherein said carbohydrate substance is selected from the group consisting of alginic acid and salts thereof, chitin, chitosan, cellulose, n-acetyl glucosamine, proteoglycans, glycolic acid polymers, lactic acid polymers, glycolic acid/lactic acid co-polymers and mixtures of two or more thereof. 9. The process of claim 1, wherein said haemostatic layer also contains a fibrin crosslinker and/or a source of calcium ions. 10. The process of claim 1, wherein said haemostatic layer also contains one or more of the following: at least one filler, at least one solubilizing agent, at least one foaming agent and at least one release agent. 11. The process of claim 10, wherein said solubilizing agent is selected from the group consisting of sucrose, lactose, maltose, dextrose, mannose, trehalose, mannitol, sorbitol, albumin, sorbate, polysorbate, and mixtures of two or more thereof. 12. The process of claim 2, wherein said haemostatic layer further contains at least one binding agent in an amount effective to improve the adherence of said haemostatic layer to said support layer. 13. The process of claim 12, wherein said binding agent is selected from the group consisting of sucrose, mannitol, sorbitol, gelatin, hyaluron, hyaluronic acid, maltose, povidone, chitosan and carboxymethylcellulose. 14. The process of claim 1, wherein said haemostatic layer is substantially homogeneous throughout. 15. The process of claim 1, wherein said haemostatic layer is a monolith. 16. The process of claim 1, wherein said frozen aqueous mixture is lyophilized in (c). 17. The process of claim 1, wherein said moisture content is at least 6%. 18. The process of claim 1, wherein said moisture content is less than 6%. 19. The process of claim 2, wherein said support layer comprises a front support material. 20. The process of claim 1, wherein said temperature is reduced to between −10° C. to −196° C. 21. The process of claim 1, wherein said temperature is reduced while said liquid aqueous mixture is frozen while in the horizontal or vertical orientation.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (76)
Redl Heinz (Vienna ATX) Habison Georg (Vienna ATX), Apparatus for applying a tissue adhesive.
Redl Heinz (Vienna ATX) Schlag Gnther (Vienna ATX) Pridun Nestor (Vienna ATX), Biologic absorbable implant material for filling and closing soft tissue cavities and method of its preparation.
Drohan William N. ; MacPhee Martin J. ; Miekka Shirley I. ; Singh Manish S. ; Elson Clive,CAX ; Taylor ; Jr. John R., Chitin hydrogels, methods of their production and use.
Errede Louis A. (North Oaks MN) Stoesz James D. (St. Paul MN) Winter ; deceased George D. (late of St. Paul MN by Jenny Upton ; personal representative), Composite wound dressing.
Brown Ross G. (Terre Haute IN) Bright David R. (Terre Haute IN) Williams Robert D. (Terre Haute IN), Fibrin binder/carrier for active biochemical agents.
Wahlig Helmut (Darmstadt DEX) Dingeldein Elvira (Dreieich DEX) Kirchlechner Richard (Rott a. Inn DEX) Orth Dieter (Darmstadt DEX) Rogalski Werner (Alsbach DEX), Flavonoid phosphate salts of aminoglycoside antibiotics.
Ron Eyal (Lexington MA) Schaub Robert G. (Pelham NH) Turek Thomas J. (Boston MA), Formulations of blood clot-polymer matrix for delivery of osteogenic proteins.
Nesburn Anthony B. (Malibu CA) Gorin Michael (Rockville MD) Martinez Marvin (Glendale CA) Kenney M. Cristina (Malibu CA) Maguen Ezra (Los Angeles CA), Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers.
Nesburn Anthony B. (Malibu CA) Gorin Michael (Rockville MD) Martinez Marvin (Glendale CA) Kenney M. Cristina (Malibu CA) Maguen Ezra (Los Angeles CA), Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers.
Nesburn Anthony B. (Malibu CA) Gorin Michael (Rockville MD) Martinez Marvin (Glendale CA) Kenney M. Cristina (Malibu CA) Maguen Ezra (Los Angeles CA), Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers.
Williams Stuart K. (Drexel Hill PA) Jarrell Bruce E. (Philadelphia PA), Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surfa.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Nondynamic fibrin monomer on bandages, sutures, prostheses and dressings.
Zimmermann Eberhard (Am Braaken 16 4400 Mnster-Nienberge DEX) Stroetmann Michael (Kaiser-Wilhelm-Ring 36 4400 Mnster DEX), Resorptive sheet material for closing and healing wounds and method of making the same.
Zimmermann Eberhard (Mnster-Nienberge DEX) Stroetmann Michael (Mnster DEX), Resorptive sheet material for closing and healing wounds and method of making the same.
MacPhee Martin James ; Drohan William Nash ; Liau Gene ; Haudenschild Christian, Supplemented and unsupplemented tissue sealants, method of their production and use.
Drohan,William N.; MacPhee,Martin J.; Burgess,Wilson H.; Nunez,Hernan; Singh,Manish; Liau,Gene; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee Martin James ; Drohan William Nash ; Lasa ; Jr. Carlos I.,PHX ; Liau Gene ; Haudenschild Christian, Supplemented and unsupplemented tissue sealants, methods of their production and use.
MacPhee Martin James ; Drohan William Nash ; Woolverton Christoper J., Supplemented and unsupplemented tissue sealants, methods of their production and use.
Tse Daphne C. ; Mankarious Samia S. ; Liu Shu Len ; Thomas William R. ; Alpern Melaine ; Enomoto Stanley T. ; Garanchon Cataline M., Topical fibrinogen complex.
Luck Edward E. (Menlo Park CA) Brown Dennis M. (Menlo Park CA), Treatments employing drug-containing matrices for introduction into cellular lesion areas.
Luck Edward E. (Menlo Park CA) Brown Dennis M. (Menlo Park CA), Treatments employing drug-containing matrices for introduction into cellular lesion areas.
Antoniades Harry N. (Newton MA) Lynch Samuel E. (Jamaica Plain MA) Williams Ray C. (Arlington MA), Wound healing and bone regeneration using PDGF and IGF-I.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.